4502Takeda Pharmaceutical Company Limited¥ --

Takeda Pharmaceutical Company Limited

4502

TSE PrimePharmaceuticals

¥ -

Takeda Pharmaceutical Company Limited (4502) statement of comprehensive income, including other comprehensive income and total comprehensive income.

The statement of comprehensive income shows net income alongside other comprehensive income, including currency translation and changes in asset values.

Statement of Comprehensive Income Details

IFRS　Unit: JPY

Item

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Profit/Loss

Valuation Difference on Available-for-sale Securities (OCI)

Remeasurements of Defined Benefit Plans (OCI)

Total of Items That Will Not Be Reclassified to Profit or Loss

Foreign Currency Translation Adjustment (OCI)

Deferred Gains/Losses on Hedges (OCI)

Hedging cost

Share of other comprehensive income of investments accounted for using equity method

Total of Items That May Be Reclassified to Profit or Loss

Total Other Comprehensive Income

Comprehensive Income

Comprehensive Income Attributable to Owners of Parent

Comprehensive Income Attributable to Non-controlling Interests

-152.1B

-5.0B

1.9B

-3.1B

903.9B

28.9B

3.2B

-541.0M

935.5B

932.4B

780.3B

780.0B

313.0M

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan